Generally speaking, the platelet count in patients with systemic lupus erythematosus (SLE) does not increase significantly.
Moreover, most patients experience damage to the hematological system. The most common manifestations are leukopenia and thrombocytopenia.
In particular, thrombocytopenia may occur because of the presence of anti - platelet antibodies or anti - phospholipid antibodies in the patient's body, as well as the maturation disorder of bone marrow megakaryocytes.
Therefore, an increase in platelet count generally does not occur.
Of course, in some patients, the platelet count is normal, and there may also be a slightly elevated situation. The possibility of chronic inflammatory response should also be ruled out.
Systemic lupus erythematosus is a lifelong disease, and patients must adhere to regular follow - up.